Trade SLBT anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
SL Science Holding Limited (SLBT) is trading at US$2.70, up 2.27% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$1.49B. Over the past 52 weeks, SLBT has traded between US$2.51 and US$14.50. On Syfe you can trade SLBT with $0 commission and add it to your watchlist.
| Previous close | US$2.64 |
|---|---|
| Market cap | US$1.49B |
| 52-week range | US$2.51 – US$14.50 |
| Volume | 40.92K |
| Exchange | US |
Add to Watchlist
Set Price Alert
SL Science Holding Limited
SL Science Holding Ltd. operates as a biomedical company. It operates through Exosome products, CD-19 Armed-T products, GDT cell therapy products, corporate and unallocated segments. The firm offers immune cell development, skincare product formulations, cellular and gene therapies. The company was founded by Ching Dong Wang on March 18, 2025 and is headquartered in Taipei, Taiwan.
Year: 2026
Sector Update: Healthcare Stocks Decline Late Afternoon
Jul 10, 7:50 PM · MT Newswires
Sector Update: Healthcare
Jul 10, 7:39 PM · MT Newswires
Sector Update: Healthcare Stocks Advance Premarket Friday
Jul 10, 1:15 PM · MT Newswires
SL Science Submits Orphan Drug Designation Request to FDA for GDT Cell Therapy in Glioblastoma
Jul 10, 12:20 PM · MT Newswires
SL Science Holding Limited (SLBT) stock is trading at US$2.70, +2.27% from the previous close of US$2.64.
The market cap for SL Science Holding Limited (SLBT) stock is approximately US$1.49B.
The 52-week high for SL Science Holding Limited (SLBT) stock is US$14.50.
The 52-week low for SL Science Holding Limited (SLBT) stock is US$2.51.
SL Science Holding Limited (SLBT) does not currently pay a dividend.
Stay on top of SLBT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
